Healthcare earnings, Epic's biggest conference of the year, Oracle Health's strategy, public healthtech stocks, and one of the industry's most talked-about investigations.In this episode of Digital Health Vitals, Alex Koshykov, Sergei Polevikov, Stephanie Davis, and special guest Bailey Morgan break down the biggest developments shaping digital health.We discuss the winners and losers of Q2 earnings, why Doximity surprised Wall Street, whether Amwell is finally turning the corner, what Epic actually announced at UGM, Oracle Health's future after Cerner, and the ongoing debate around the Stat investigation into Commure. We also cover R1's latest acquisitions and what they mean for the future of revenue cycle management and prior authorization.Whether you're a founder, investor, provider, or simply interested in healthcare innovation, this episode offers practical insights into where digital health is heading.Host/Moderator:Alex Koshykov — CEO @ YODD, COO @ BeKey.io https://www.linkedin.com/in/alex-koshykov/Experts:Sergei Polevikov @sergeiAI — Founder of AI Health Uncut https://www.linkedin.com/in/sergeiai/AI Health Uncut: https://FixHealth.aiStephanie Davis — Healthcare Industry Analyst https://www.linkedin.com/in/stephjdavis/Bailey Morgan - Chief of Staff @ Groth Pain & Spinehttps://www.linkedin.com/in/bailey-morgan7/Topics covered:- Q2 healthtech earnings: winners, losers, and what Wall Street is signaling- Why Teladoc continues to struggle while Talkspace gains momentum- Doximity's strong quarter and whether OpenEvidence is a real competitive threat- Can Amwell finally complete its turnaround?- Epic UGM 2026: biggest AI announcements and product launches- Epic vs Oracle Health: who will shape the future of the EHR market?- Ambient AI, clinical decision support, and the battle between Epic, Abridge, Microsoft, and Nuance- Is Epic becoming too dominant in healthcare?- Oracle Health, Cerner, and the future of the VA modernization project- The Commure investigation: partnerships, referral fees, and healthcare business ethics- R1's AI strategy and the future of revenue cycle management- Prior authorization automation, CMS rules, and where healthcare operations are heading